Join
Live feed
·
INSIDERFilingvia Quantisnow
Ernexa Therapeutics Inc. logo

New insider Polinsky David claimed ownership of 8,000 shares (SEC Form 3)

ByQuantisnow·Wall Street's wire, on your screen.
ERNA· Ernexa Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ERNA (Ernexa Therapeutics Inc.) and more on Quantisnow.